In glioblastomas, IRAK4 (Interleukin 1 Receptor Associated Kinase 4) is upregulated after temozolomide (TMZ) treatment in glioma cells and mediates Toll-like receptor signaling and chemoresistance [31]. Here, IRAK4 is linked to glioma.